Increasing time trends of thin melanomas in the Netherlands: What are the explanations of recent accelerations?

European Journal of Cancer

Volumn 51, Issue 18, 2015, Pages 2833-2841

  Van Der Leest, Robert J T ^a   Zoutendijk, Judith ^a   Nijsten, Tamar ^a   Mooi, Wolter J ^b   Van Der Rhee, Jasper I ^c,d   De Vries, Esther ^a,e   Hollestein, Loes M ^a,f  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d Medical Centre Alkmaar   (Netherlands)

^e Instituto Nacional de Cancerología   (Colombia)

^f Netherlands Comprehensive Cancer Organisation ^*  (Netherlands)

Author keywords

Breslow thickness; In situ melanoma; Incidence; Melanoma; Overdiagnosis; Thin melanoma

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BRESLOW THICKNESS; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER INCIDENCE; CHILD; CLINICAL ASSESSMENT; CLINICAL EVALUATION; COMPARATIVE STUDY; CUTANEOUS MELANOMA; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MELANOMA; NETHERLANDS; NEWBORN; ONCOLOGICAL PARAMETERS; PRIORITY JOURNAL; SEX ALLOCATION; ADVERSE EFFECTS; AGE; EARLY DIAGNOSIS; HEALTH SERVICE; INCIDENCE; MIDDLE AGED; PATHOLOGY; PREDICTIVE VALUE; PRESCHOOL CHILD; REGISTER; RISK FACTOR; SEX DIFFERENCE; SEX RATIO; SKIN NEOPLASMS; STATISTICAL MODEL; TIME; TUMOR INVASION; ULTRAVIOLET RADIATION; YOUNG ADULT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGE FACTORS; AGED; CHILD; CHILD, PRESCHOOL; EARLY DETECTION OF CANCER; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; LINEAR MODELS; MALE; MEDICAL OVERUSE; MELANOMA; MIDDLE AGED; NEOPLASM INVASIVENESS; NETHERLANDS; PREDICTIVE VALUE OF TESTS; REGISTRIES; RISK FACTORS; SEX DISTRIBUTION; SEX FACTORS; SKIN NEOPLASMS; TIME FACTORS; ULTRAVIOLET RAYS; YOUNG ADULT;

EID: 84958742139     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2015.09.008     Document Type: Article

References (41)

1. Comprehensive Cancer Centre Netherlands. http://www.cijfersoverkanker.nl/ [accessed 08.11.15].
2. L.M. Hollestein, S.A. van den Akker, T. Nijsten, and et al. Trends of cutaneous melanoma in the Netherlands: Increasing incidence rates among all Breslow thickness categories and rising mortality rates since 1989 Ann Oncol 23 2012 524 530
3. A. Montella, A. Gavin, R. Middleton, and et al. Cutaneous melanoma mortality starting to change: A study of trends in Northern Ireland Eur J Cancer 45 2009 2360 2366
4. M. Coory, P. Baade, J. Aitken, and et al. Trends for in situ and invasive melanoma in Queensland, Australia, 1982-2002 Cancer Causes Control 17 2006 21 27
5. E. de Vries, L.J. Schouten, O. Visser, and et al. Rising trends in the incidence of and mortality from cutaneous melanoma in the Netherlands: A northwest to southeast gradient? Eur J Cancer 39 2003 1439 1446
6. E. de Vries, and J.W. Coebergh Cutaneous malignant melanoma in Europe Eur J Cancer 40 2004 2355 2366
7. G. Bentham, and A. Aase Incidence of malignant melanoma of the skin in Norway, 1955-1989: Associations with solar ultraviolet radiation, income and holidays abroad Int J Epidemiol 25 1996 1132 1138
8. V. De Giorgi, A. Gori, M. Grazzini, and et al. Epidemiology of melanoma: Is it still epidemic? What is the role of the sun, sunbeds, Vit D, betablocks, and others? Dermatol Ther 25 2012 392 396
9. L.J. Schouten, H. Straatman, L.A. Kiemeney, and et al. The capture-recapture method for estimation of cancer registry completeness: A useful tool? Int J Epidemiol 23 1994 1111 1116
10. G.A. van der Sanden, J.W. Coebergh, L.J. Schouten, and et al. Cancer incidence in the Netherlands in 1989 and 1990: First results of the nationwide Netherlands cancer registry. Coordinating Committee for Regional Cancer Registries Eur J Cancer 31A 1995 1822 1829
11. A. Fritz, C. Percy, A. Jack, and et al. International classification of diseases for oncology, Third Edition. (ICD-O3) 2002 World Health Organization Geneva, Switzerland
12. C.M. Balch, J.E. Gershenwald, S.J. Soong, and et al. Final version of 2009 AJCC melanoma staging and classification J Clin Oncol 27 2009 6199 6206
13. R.J. van der Leest, L.N. van Steenbergen, L.M. Hollestein, and et al. Conditional survival of malignant melanoma in the Netherlands: 1994-2008 Eur J Cancer 50 2014 602 610
14. H.J. Kim, M.P. Fay, B. Yu, and et al. Comparability of segmented line regression models Biometrics 60 2004 1005 1014
15. Joinpoint Regression Program, Version 4.0 Statistical methodology and applications branch, surveillance research program December 2012 National Cancer Institute
16. H.J. Kim, M.P. Fay, E.J. Feuer, and et al. Permutation tests for joinpoint regression with applications to cancer rates Stat Med 19 2000 335 351
17. F. Erdmann, J. Lortet-Tieulent, J. Schuz, and et al. International trends in the incidence of malignant melanoma 1953-2008-are recent generations at higher or lower risk? Int J Cancer 132 2013 385 400
18. E. de Vries, F.I. Bray, J.W. Coebergh, and et al. Changing epidemiology of malignant cutaneous melanoma in Europe 1953-1997: Rising trends in incidence and mortality but recent stabilizations in western Europe and decreases in Scandinavia Int J Cancer 107 2003 119 126
19. P. Baade, X. Meng, D. Youlden, and et al. Time trends and latitudinal differences in melanoma thickness distribution in Australia, 1990-2006 Int J Cancer 130 2012 170 178
20. A.C. Green, P. Baade, M. Coory, and et al. Population-based 20-year survival among people diagnosed with thin melanomas in Queensland, Australia J Clin Oncol 30 2012 1462 1467
21. A.C. Geller, R.W. Clapp, A.J. Sober, and et al. Melanoma epidemic: An analysis of six decades of data from the Connecticut Tumor Registry J Clin Oncol 31 2013 4172 4178
22. V.D. Criscione, and M.A. Weinstock Melanoma thickness trends in the United States, 1988-2006 J Invest Dermatol 130 2010 793 797
23. J. Lyth, H. Eriksson, J. Hansson, and et al. Trends in cutaneous malignant melanoma in Sweden 1997-2011: Thinner tumours and improved survival among men Br J Dermatol 172 3 2015 Mar 700 706 10.1111/bjd.13483
24. R.M. MacKie, C. Bray, J. Vestey, and et al. Melanoma incidence and mortality in Scotland 1979-2003 Br J Cancer 96 2007 1772 1777
25. A. Armstrong, C. Powell, R. Powell, and et al. Are we seeing the effects of public awareness campaigns? A 10-year analysis of Breslow thickness at presentation of malignant melanoma in the South West of England J Plast Reconstr Aesthet Surg 67 2014 324 330
26. D.C. Whiteman, P.D. Baade, and C.M. Olsen More people die from thin melanomas (1 mm) than from thick melanomas (>4 mm) in Queensland, Australia J Invest Dermatol 135 4 2015 Apr 1190 1193 10.1038/jid.2014.452
27. H.G. Welch, and W.C. Black Overdiagnosis in cancer J Natl Cancer Inst 102 2010 605 613
28. E.W. Breitbart, A. Waldmann, S. Nolte, and et al. Systematic skin cancer screening in Northern Germany J Am Acad Dermatol 66 2012 201 211
29. R.A. Swerlick, and S. Chen The melanoma epidemic. Is increased surveillance the solution or the problem? Arch Dermatol 132 1996 881 884
30. A. Katalinic, A. Waldmann, M.A. Weinstock, and et al. Does skin cancer screening save lives?: An observational study comparing trends in melanoma mortality in regions with and without screening Cancer 118 2012 5395 5402
31. A.D. Krol, H.J. van der Rhee, M. Dieleman, and et al. The 'freckle bus' campaign; an unhealthy phenomenon or a sensible experiment? [Article in Dutch] Ned Tijdschr Geneeskd 134 42 1990 2047 2050
32. M.J. de Rooij, F.H. Rampen, L.J. Schouten, and et al. Volunteer melanoma screenings. Follow-up, compliance, and outcome Dermatol Surg 23 3 1997 Mar 197 201 http://www.ncbi.nlm.nih.gov/pubmed/9145963-comments
33. H.G. Welch, S. Woloshin, and L.M. Schwartz Skin biopsy rates and incidence of melanoma: Population based ecological study BMJ 331 2005 481
34. E.J. Glusac The melanoma 'epidemic', a dermatopathologist's perspective J Cutan Pathol 38 2011 264 267
35. C. Erickson, and M.S. Driscoll Melanoma epidemic: Facts and controversies Clin Dermatol 28 2010 281 286
36. J.E. Frangos, L.M. Duncan, A. Piris, and et al. Increased diagnosis of thin superficial spreading melanomas: A 20-year study J Am Acad Dermatol 67 2012 387 394
37. C. Héry, L. Tryggvadóttir, T. Sigurdsson, and et al. A melanoma epidemic in Iceland: Possible influence of sunbed use Am J Epidemiol 172 7 2010 762 767
38. P. Autier, A. Koechlin, and M. Boniol The forthcoming inexorable decline of cutaneous melanoma mortality in light-skinned populations Eur J Cancer 51 7 2015 869 878
39. S.C. Flohil, I. Seubring, M.M. van Rossum, and et al. Trends in basal cell carcinoma incidence rates: A 37-year Dutch observational study J Invest Dermatol 133 2013 913 918
40. L.M. Hollestein, E. de Vries, and T. Nijsten Trends of cutaneous squamous cell carcinoma in the Netherlands: Increased incidence rates, but stable relative survival and mortality 1989-2008 Eur J Cancer 48 2012 2046 2053
41. M.A. van der Aa, E. de Vries, H.J. Hoekstra, and et al. Sociodemographic factors and incidence of melanoma in the Netherlands, 1994-2005 Eur J Cancer 47 2011 1056 1060